First to be vaccinated will be health workers, contacts of confirmed Ebola patients.
For adolescents and young adults, the co-administration of quadrivalent meningococcal conjugate vaccine with incorporated tetanus toxoid with diphtheria-tetanus-acellular pertussis vaccine is noninferior to isolated vaccination and does not compromise immunity.
A significant decline in rotavirus disease-associated hospitalization, emergency department visits, and physician office visits was demonstrated in children younger than 5 years following implementation of the rotavirus vaccine.
Women receiving the inactivated influenza vaccine demonstrated superior antibody response compared with those receiving the live attenuated influenza vaccine.
Vaccinated women and girls living with HIV may be at greater risk for HPV vaccine failure compared with women and girls without HIV.
Less than a year following the initial direct-to-tumor vaccine injection, all treated tumors disappeared.
Exemption from vaccination is common in Arizona school districts due to lack of trust in medical establishments.
Inverse association identified between NME rate and MMR vaccine coverage of kindergarteners.
The administration of PCV7 and PCV13 reduced the number of ambulatory visits for otitis media in pediatric patients.
Using state- and individual-level data from the 1995-2014 National Immunization Survey, the effect of a state's Universal Purchase adoption on vaccination rates was estimated.
Adherence and completion to multidose vaccine schedules for hepatitis A, B, and A-B are low, thereby rendering vaccination ineffective.
Others have argued that dismissal is ethically problematic because it can deprive children of comprehensive pediatric care and undermine public health.
With the advent of platform manufacturing technology, vaccines can be developed quickly to stop the spread of outbreaks.
The 2017-2018 influenza season in the United States (October 1, 2017-May 19, 2018) was a high-severity season.
From 2007 to 2015, the majority of initial hepatitis A, B, and A/B vaccinations were administered by primary care providers.
Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis.
The risk of intussusception within 1 to 7 days and 8 to 21 days after rotavirus vaccination was assessed in infants age 28 to 245 days.
Early vaccination of autologous hemopoietic stem-cell transplant (auto-HSCT) recipients during the peri-transplant period can be effective for the prevention of infections such as herpes zoster.
The hexavalent DTPa-HBV-IPV/Hib vaccine may not affect Hib vaccine efficacy.
The CDC recommends 2 doses of the MMR vaccine, which provides 97% protection against measles, prior to international travel.
High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years
This updated Committee Opinion includes more recent data on the safety and efficacy of influenza vaccination during pregnancy, as well as recommendations for treatment and postexposure chemoprophylaxis.
Zika virus shown to be of moderate to high efficacy in eliminating prenatal infections.
TDF did not reduce mother-to-child HBV transmission in mothers taking hepatitis B Ig and HBV vaccine.
Clinicians using communication training and fact sheets to inform adolescents about HPV, significantly increased vaccination initiation and completion rates among their patients.
Increasing awareness of and access to newer HIV testing options such as free or reduced price on home and self-tests and couples HIV testing and counseling can facilitate increased levels of consistent testing among young, Black MSM, and transgender women.
The 2017 to 2018 influenza vaccine reduces the chance of getting the disease by about 33%, but is only 25% effective against H3N2, otherwise known as influenza A.
No increased risk of incident epilepsy was seen among children who received influenza vaccination during the 2009-2010 influenza season in Norway.
The Advisory Committee on Immunization Practices updated its immunization recommendations for adults.
The updates contain new or revised ACIP recommendations for poliovirus, influenza, and measles, mumps, and rubella vaccines, as well as a clarification of the recommendations for rotavirus and pneumococcal vaccines.